Literature DB >> 17976350

Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?

Ayalew Tefferi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17976350     DOI： 10.4065/82.11.1316

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  3 in total

Review 1.  Pharmacotherapy for Friedreich ataxia.

Authors:  Amy Y Tsou; Lisa S Friedman; Robert B Wilson; David R Lynch
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 2.  Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease.

Authors:  Monique P Curran; Paul L McCormack
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Therapeutic developments in Friedreich ataxia.

Authors:  Robert B Wilson
Journal:  J Child Neurol       Date:  2012-07-12       Impact factor: 1.987
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.